K2 Oncology, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients (NCT03453307) | K2 Oncology, Inc. | 2018-01-30 |
Track K2 Oncology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.